Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report.

Arteriosclerosis, thrombosis, and vascular biology - 5 May 2021

Reeskamp Laurens F, Millar John S, Wu Liya, Jansen Hans, van Harskamp Dewi, Schierbeek Henk, Gipe Daniel A, Rader Daniel J, Dallinga-Thie Geesje M, Hovingh G Kees, Cuchel Marina

Abstract excerpt

[Figure: see text].

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiopoietin-Like Protein 3
Share to Angiopoietin-like Proteins
Share to Anticholesteremic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein B-100

Share to Hyperlipoproteinemia Type II

Share to Lipoproteins, LDL

Share to Pennsylvania

Share to Receptors, LDL

Source

Open in PubMed Open full text

Identifiers

PMID: 33691480
DOI: 10.1161/ATVBAHA.120.315204
PMCID: PMC8057526

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report.PMID 33691480Read ↗

How ANGPTL3 Inhibition Will Help Our Clinical Practice?Semantic proximity Read ↗

ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases.Semantic proximity Read ↗

Evinacumab for Homozygous Familial Hypercholesterolemia.Semantic proximity Read ↗

Evidence for improved survival with treatment of homozygous familial hypercholesterolemiaSemantic proximity Read ↗

Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study.Semantic proximity Read ↗

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.Semantic proximity Read ↗

ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia.Semantic proximity Read ↗

Lipoprotein Apheresis: An Established Therapeutic Modality for Homozygous Familial Hypercholesterolemia Patients Refractory to PCSK9 Inhibitors: A Case Report and Literature ReviewSemantic proximity Read ↗

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Semantic proximity Read ↗

New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.Semantic proximity Read ↗

Lomitapide for the treatment of hypercholesterolemia.Semantic proximity Read ↗

Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.